Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 02/27/22
Due: 02/27/23
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 07/30/21
End: 02/27/23
Due: 02/27/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Changes in Carotid Plaque Neovascularization After Elovocumab Therapy | NCT04423406 | Zibo Central Hospital | user2@example.com | None | 2020-08-01 | 2022-02-27 | 2023-02-27 | - | - | 2025-07-14 |
| Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy | NCT05802108 | Zibo Central Hospital | user2@example.com | None | 2022-07-01 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |
| Hemodynamic Change of Coronary Atherosclerotic Plaque After Evolocumab Treatment | NCT04416425 | Zibo Central Hospital | user2@example.com | None | 2021-07-30 | 2023-02-27 | 2024-02-27 | - | - | 2025-07-14 |